Results 11 to 20 of about 694,820 (288)
Cardiovascular Diabetology, 2023 Background The triglyceride-glucose (TyG) index and triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, two simple surrogate indicators of insulin resistance, have been demonstrated to predict cardiovascular disease (CVD).
Bizhong Che +6 more
semanticscholar +1 more source
Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
Cardiovascular Diabetology, 2022 The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker of insulin resistance (IR). Recently, a considerable number of studies have provided robust statistical evidence suggesting that the TyG index is associated with
Lichan Tao +4 more
semanticscholar +1 more source
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
New England Journal of Medicine, 2022 BACKGROUND High triglyceride levels are associated with increased cardiovascular risk, but whether reductions in these levels would lower the incidence of cardiovascular events is uncertain.
Aruna Das Pradhan +35 more
semanticscholar +1 more source
Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance.
JPMA. The Journal of the Pakistan Medical Association, 2022 The predictability of triglyceride glucose index (TyG index) as a biomarker for identification of insulin resistance (IR) is being extensively studied in various ethnic populations.
Vineetha K. Ramdas Nayak +3 more
semanticscholar +1 more source
Triglyceride cycling enables modification of stored fatty acids
Nature Metabolism, 2023 Triglyceride cycling is the process of continuous degradation and re-synthesis of triglyceride in cellular stores. We show in 3T3-L1 adipocytes that triglycerides are subject to rapid turnover and re-arrangement of fatty acids with an estimated half-life
Klaus Wunderling +4 more
semanticscholar +1 more source
International Journal of Endocrinology, 2020 Introduction. The triglyceride and glucose (TyG) index has been described as a biochemical marker of insulin resistance (IR); however, its diagnostic accuracy remains uncertain. Objective To summarize the evidence assessing the diagnostic accuracy of the
A. Sánchez‐García +7 more
semanticscholar +1 more source
Frontiers in Cardiovascular Medicine, 2021 Background: Atherosclerosis is a major cause of coronary artery disease (CAD), and CAD is one of the main causes leading to death in most countries. It has been reported that lncRNAs play important roles in the development of atherosclerosis; thus, we ...
Limin Sun +4 more
doaj +1 more source
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
Biomedicines, 2021 Despite advances in pharmacotherapy, intervention devices and techniques, residual cardiovascular risks still cause a large burden on public health. Whilst most guidelines encourage achieving target levels of specific lipids and lipoproteins to reduce ...
Chih-Kuo Lee +5 more
doaj +1 more source
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
New England Journal of Medicine, 2019 BACKGROUND Familial chylomicronemia syndrome is a rare genetic disorder that is caused by loss of lipoprotein lipase activity and characterized by chylomicronemia and recurrent episodes of pancreatitis. There are no effective therapies.
J. Witztum +18 more
semanticscholar +1 more source
Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients
Cardiovascular Diabetology, 2020 Da Silva et al. showed that the triglyceride-glucose (TyG) index was positively associated with a higher prevalence of symptomatic coronary artery disease (CAD). TyG has been used in healthy individuals as a marker of insulin resistance.
J. Alizargar, C. Bai, N. Hsieh, S. Wu
semanticscholar +1 more source